REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 109 filers reported holding REPLIMUNE GROUP INC in Q2 2021. The put-call ratio across all filers is 4.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,579,423 | +47.4% | 267,646 | +100.0% | 0.01% | +50.0% |
| Q2 2023 | $3,107,370 | +21.7% | 133,823 | -7.4% | 0.00% | +33.3% |
| Q1 2023 | $2,552,983 | -29.4% | 144,563 | +8.7% | 0.00% | -25.0% |
| Q4 2022 | $3,616,594 | +107.3% | 132,963 | +26.6% | 0.00% | +100.0% |
| Q3 2022 | $1,745,000 | -4.9% | 105,001 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,835,000 | -8.1% | 105,001 | -10.7% | 0.00% | 0.0% |
| Q1 2022 | $1,996,000 | -42.6% | 117,523 | -8.4% | 0.00% | -33.3% |
| Q4 2021 | $3,479,000 | +0.5% | 128,361 | +9.9% | 0.00% | -25.0% |
| Q3 2021 | $3,461,000 | +1.4% | 116,775 | +12.0% | 0.00% | +33.3% |
| Q2 2021 | $3,413,000 | +52.3% | 104,275 | +42.0% | 0.00% | 0.0% |
| Q1 2021 | $2,241,000 | -10.7% | 73,437 | +11.6% | 0.00% | 0.0% |
| Q4 2020 | $2,510,000 | +426.2% | 65,801 | +217.9% | 0.00% | +200.0% |
| Q3 2020 | $477,000 | -7.2% | 20,700 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $514,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |